Your browser doesn't support javascript.
loading
Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality.
Smadja, David M; Philippe, Aurélien; Bory, Olivier; Gendron, Nicolas; Beauvais, Agathe; Gruest, Maxime; Peron, Nicolas; Khider, Lina; Guerin, Coralie L; Goudot, Guillaume; Levavasseur, Françoise; Duchemin, Jérome; Pene, Frédéric; Cheurfa, Cherifa; Szwebel, Tali-Anne; Sourdeau, Elise; Planquette, Benjamin; Hauw-Berlemont, Caroline; Hermann, Bertrand; Gaussem, Pascale; Samama, Charles-Marc; Mirault, Tristan; Terrier, Benjamin; Sanchez, Olivier; Rance, Bastien; Fontenay, Michaela; Diehl, Jean-Luc; Chocron, Richard.
Affiliation
  • Smadja DM; Université de Paris, Innovative Therapies in Haemostasis, INSERM, Paris, France.
  • Philippe A; Hematology Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
  • Bory O; Université de Paris, Innovative Therapies in Haemostasis, INSERM, Paris, France.
  • Gendron N; Hematology Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
  • Beauvais A; Université de Paris, Emergency Department, Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
  • Gruest M; Université de Paris, Innovative Therapies in Haemostasis, INSERM, Paris, France.
  • Peron N; Hematology Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
  • Khider L; Université de Paris, Emergency Department, Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
  • Guerin CL; Université de Paris, Innovative Therapies in Haemostasis, INSERM, Paris, France.
  • Goudot G; Hematology Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
  • Levavasseur F; Université de Paris, Intensive Care Department, Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
  • Duchemin J; Université de Paris, Vascular Medicine Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
  • Pene F; Université de Paris, Innovative Therapies in Haemostasis, INSERM, Paris, France.
  • Cheurfa C; Curie Institute, Cytometry Department, Paris, France.
  • Szwebel TA; Université de Paris, Vascular Medicine Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
  • Sourdeau E; Université de Paris, Institut Cochin, INSERM, Paris, France.
  • Planquette B; Hematology Department Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
  • Hauw-Berlemont C; Université de Paris, Institut Cochin, INSERM, Paris, France.
  • Hermann B; Hematology Department Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
  • Gaussem P; Internal Medicine Department, Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
  • Samama CM; Intensive Care Medicine and Reanimation Department, Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
  • Mirault T; Internal Medicine Department, Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
  • Terrier B; Emergency Unit, Hôpital Hôtel-Dieu, Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
  • Sanchez O; Université de Paris, Innovative Therapies in Haemostasis, INSERM, Paris, France.
  • Rance B; Respiratory Medicine Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
  • Fontenay M; Université de Paris, Intensive Care Department, Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
  • Diehl JL; Université de Paris, Intensive Care Department, Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
  • Chocron R; Université de Paris, Innovative Therapies in Haemostasis, INSERM, Paris, France.
J Thromb Haemost ; 19(7): 1823-1830, 2021 07.
Article in En | MEDLINE | ID: mdl-33830623
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vascular Endothelial Growth Factor A / COVID-19 Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vascular Endothelial Growth Factor A / COVID-19 Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2021 Document type: Article Affiliation country: Country of publication: